Health Boards
Fri-21-11-2014, 13:25 PM
But now it is interesting and bad news for our friends with MS.
Previously there was a medication Lemtrada, or alemtuzumab, which was working against leukemia.
It was removed from the market in 2012.
Now recently it has been set back into the market, because it also appears to slow down the progress of MS, exactly the same product, for a price ................... 40 times more expensive.
Previously there was a medication Lemtrada, or alemtuzumab, which was working against leukemia.
It was removed from the market in 2012.
Now recently it has been set back into the market, because it also appears to slow down the progress of MS, exactly the same product, for a price ................... 40 times more expensive.
